IMAGE
Figure 4.1.JPG (18.8 kB)
IMAGE
Figure 4.2.JPG (59.18 kB)
IMAGE
Figure 4.3.JPG (51.17 kB)
IMAGE
Figure 4.4.JPG (52 kB)
IMAGE
Figure 5.1.JPG (26.89 kB)
IMAGE
Figure 5.2.JPG (75.55 kB)
IMAGE
Figure 5.3.JPG (35.26 kB)
IMAGE
Figure 5.4.JPG (55.12 kB)
IMAGE
Figure 5.5.JPG (31.27 kB)
IMAGE
Figure 5.6.JPG (44.28 kB)
IMAGE
Figure 6.1.JPG (63.44 kB)
IMAGE
Figure 6.2.JPG (61.12 kB)
IMAGE
Figure 6.3.JPG (50.85 kB)
IMAGE
Figure 6.4.JPG (20.17 kB)
IMAGE
Figure 6.5.JPG (20.08 kB)
IMAGE
Table 2.1.JPG (56.53 kB)
IMAGE
Table 3.3.1.JPG (38.61 kB)
IMAGE
Table 3.3.2.JPG (96.65 kB)
IMAGE
Table 4.1.JPG (31.38 kB)
IMAGE
Table 4.2.JPG (29.02 kB)
1/0
The ex vivo addition of vitamin D on the prothrombotic and the fribrinolytic potential in prostate cancer patients' blood
Datasets involved in the investigation on the effect of vitamin D supplementation on clotting parameters and morphology in prostate cancer patients. Datasets underpin the study "The effect of the ex vivo addition of vitamin D on the prothrombotic and fibrinolytic potential in prostate cancer patints' blood". The study investigated the hypercoagulable state of both metastatic and nonmetastatic PCa patients, in comparison to a reference group, before and after the ex vivo supplementation with vitamin D.
